Heart failure and transthyretin amyloid cardiomyopathy (ATTR-CM)

  • Payer value proposition and communication for a new remote patient monitoring platform in congestive heart failure
  • Objection handlers in transthyretin amyloid cardiomyopathy (ATTR-CM)
  • Objection handler and value story updates in ATTR-CM
  • Payer research/interviews and value proposition testing in ATTR-CM
  • Disease area review, burden of illness and unmet needs in heart failure (and associated renal dysfunction)
  • Development of a PRO dossier for the Minnesota Living with Heart Failure Questionnaire and selection of a validated dyspnoea questionnaire
  • Content validity of a symptom endpoint and dossier in heart failure with preserved ejection fraction
  • Consultation on the validation of a primary clinical endpoint in heart failure
  • Chart review of heart failure in China
  • Meetings for a heart failure study
  • Heart failure chart review in China
  • Caregiver burden in patients with chronic heart failure
  • Psychometric validation of the chronic heart failure (CHF) caregiver burden questionnaire
  • Support for additional translations of the Heart Failure Compliance Questionnaire (HFCQ) for chronic heart failure
  • Network meta-analysis of pharmacological treatment of heart failure
  • Selection of a caregiver burden questionnaire for acute decompensated heart failure